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The scope of this article is to outline some of the basic methods for good quality RNA preparation from mammalian tissues and cells
(including epithelial cells). Additionally, we give an outline of common techniques of measuring CFTR gene expression such as quantitative
and semi-quantitative reverse transcription (RT) PCR and ribonuclease protection assay (RPA). These methods are designed to detect low
abundance transcripts, which apply to CFTR mRNA in most cell types and tissues.
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1. Transcript analysis 2. Methods for RNA extractionThe fundamental question in the analysis of gene ex-
pression at the RNA level is whether messenger RNA
(mRNA), derived from a gene of interest, is present in cells
or tissues.
Ordinarily, mRNA makes up less than 6% of the total
RNA content of a cell or tissue. When RNA is isolated from
these sources, all RNA species are present, that is, ribosom-
al, transfer small RNA molecules besides mRNA. Many
methods and kits exist for RNA extraction from cells and
tissues as well as for cDNA preparation and analysis of gene
transcripts. All protocols included here are also described in
detail elsewhere [1].1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2004.05.004
Abbreviations: ATC, aurintricarboxylic; BSA, bovine serum albumin;
cpm, counts per minute; DEPC, diethyl pyrocarbonate; RPA, ribonuclease
protection assay; RT, reverse transcriptase; TE, Tris–EDTA buffer.
* Corresponding author. Tel.: +30-210-7467461; fax: +30-210-
7795553.
E-mail address: mtzeti@cc.uoa.gr (M. Tzetis).2.1. Preservation of biological samples for RNA extraction
A ribonuclease (RNAse)-retarding solution (consisting of
25 mM sodium citrate; 10 mM EDTA; 10 M ammonium
sulphate; pH 5.2 by addition of 1 M H2SO4), presents an
alternative to the commercially available RNAlaterk (Qia-
gen, Hilden, Germany) preservation solution. It can be used
for storage of cells from a variety of sources (nasal brushing
cells or harvested cultured cell lines). It penetrates harvested
cells and retards RNA degradation to a rate dependent on the
storage temperature (1 day at 37 jC, 1 week at room
temperature, and 1 month at 4 jC or indefinitely at  20
or  80 jC). Following storage, cells may be recovered in a
pellet for RNA extraction by centrifugation at 3000 g for
5 min at 4 jC.
2.2. Protocol for RNA extraction from nasal epithelial cells
This RNA extraction procedure is appropriate for the
preparation of RNA to be used as a substrate in a variety ofed by Elsevier B.V. All rights reserved.
2 This procedure cannot be adopted when the RNA is tube used in any
enzymatic reaction (e.g. cDNA synthesis, in vitro translation, etc.) as ATC
inhibits these reactions.
1 DEPC water: Add 0.2% diethyl pyrocarbonate (DEPC) to distilled
water. Stir for 30 min. Heat to boiling while stirring until 1/4 volume has
evaporated. Autoclave for 20 min. DEPC-treated water needs to be
prepared in a chemical hood with proper exhaust ventilation.
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sion [2,3]. The protocol is adapted from the one provided
with the RNeasy mini kit (Qiagen, cat no. 74104). Nasal
epithelial cells are collected from the nasal epithelium by
gently brushing the inferior turbinates of both nostrils [4]
using interdental brushes (2 or 3 mm supplied by Paro-Isola,
Thalwil, Switzerland). The brush is introduced into a micro-
centrifuge tube containing 350 Al extraction buffer RLT
(Qiagen), supplemented with 1% (v/v) h-mercaptoethanol.
Cell lysates can be stored in the buffer at  80 jC for
several months. Frozen lysates are incubated at 37 jC for 10
min to dissolve all salt. The lysate is transferred to a
QIAshredder column (Qiagen), ensuring that all liquid from
the brush is removed by additionally centrifuging the micro-
centrifuge tube containing the brush. Homogenization is
achieved by spinning for 2 min at 3000 g. Alternatively
cells are homogenized by passing the lysate 10 times
through a 20-gauge (G) needle fitted to a syringe. Three
hundred and fifty microliters of 70% (v/v) ethanol is added
to the column eluate, mixed well by pipetting, and trans-
ferred to an RNeasy mini column (Qiagen) and spun for 15 s
at 3000 g. Seven hundred microliters of RW1 buffer
(Qiagen) is pipetted to the RNeasy column and centrifuged
as above. The column is transferred to a new tube and 500
Al of RPE buffer (Qiagen) is added onto the column and
spun as above to wash the column. The procedure is
repeated with buffer RPE, the column is transferred to a
new tube and centrifuged for 2 min at 3000 g (all ethanol
should be washed out from the membrane). Finally, the
column is transferred to a new 1.5-ml collection tube and 50
Al of RNAse-free water is pipetted to the middle of the
membrane, incubated for 1 min at room temperature and
centrifuged for 1 min at 3000 g. The RNA sample is
stored at  80 jC.
2.3. Extraction of total RNA from mammalian cells or tissue
using cesium chloride
The procedure for total RNA extraction using guanidine
thiocyanate and cesium chloride centrifugation was initially
applied to pancreatic tissue, which is very rich in RNAses
[5]. It yields RNA of superior quality that can be used for
many applications including Northern blotting, RT-PCR,
ribonuclease protection assay (RPA). Cell pellet (108 cells
in 2–3 ml) or tissue (1 g/16 ml) is lysed in 4 M guanidine
thiocyanate buffer (for cells: 4 M guanidine thiocyanate;
0.5% (w/v) sarkosyl; 7 mM sodium citrate; pH 7.0; or for
tissue: 4 M guanidine thiocyanate; 0.1 M Tris–HCl pH 7.5).
The solution is filtered and stored in 10-ml aliquots at room
temperature. For tissue homogenizations, 0.5% (w/v) sodi-
um N-laurosylsarcosinate and 1% (v/v) h-mercaptoethanol
are added to the homogenate. The cell lysate or tissue
homogenate is passed through sterile syringe needles of
decreasing gauge size (18G > 23G>26G) to reduce the
solution viscosity. The lysates can be stored at  80 jC
for up to 2 months. Two to three milliliters of cell lysate areloaded onto 8 ml of cesium chloride gradient (0.1 M sodium
acetate pH 5.0; 5 mM sodium EDTA; 4.7 M cesium
chloride; pH not adjusted; filtered and autoclaved) in a
sterile centrifuge tube (Beckman 331374 for SW40 rotor,
L8-80M ultracentrifuge), and spun at 155,000 g for 16 h at
20 jC. The supernatant is discarded by carefully pipetting
from the top to about 1–2 cm from bottom of the tube and
slowly inverting the tube onto a clean filter paper. The
residual liquid from the tube walls is removed using sterile
cotton swabs and the pellet dried for another 2–5 min
(pellet may be invisible). It is then re-suspended in 150
Al elution buffer (10 mM Tris–HCl; 5 mM EDTA; 1% (w/v)
SDS) and extracted with one volume chloroform/1-butanol
(4:1). The aqueous phase is recovered and the organic phase
re-extracted with 150 Al elution buffer. The two aqueous
phases are pooled and 30 Al of sterile 3.3 M sodium acetate,
pH 5.2 and 660 Al of 100% ethanol are added and precip-
itated for a minimum of 6 h at  20 jC. The solution is
centrifuged at 10,000–12000 g at 4 jC in a microfuge,
the supernatant is discarded and the pellet washed in 70%
(v/v) ethanol and dried under vacuum. The RNA pellet is
finally re-suspended in 50–200 Al sterile diethyl pyrocar-
bonate (DEPC)1-treated water and the absorbance read at
260 nm and 280 nm. The ratio A260/A280z 1.5 is indicative
for good quality RNA [5].
2.4. Protocol for extraction of total cytoplasmic RNA from
cultured cells
This extraction protocol produces excellent quality RNA
for Northern blot analysis2 [6] and avoids contamination
with both DNA and hnRNA, as nuclei remain intact. Cells
are washed twice with PBS, and adherent cells are collected
by using a ‘‘rubber policeman’’ and centrifuged in a micro-
fuge for 1 min at 8000 g at 4 jC. The supernatant is
discarded and the cell pellet washed with 10 mM Tris–HCl,
pH 7.5 and re-suspended in 500 Al buffer M (100 mM Tris–
HCl; 1 mM EDTA; 100 mM h-mercaptoethanol; 50 AM
aurintricarboxylic (ATC) acid (as an RNase inhibitor); pH
8.5). Cells are then lysed by addition of non-ionic detergent
Nonidet P-40 (NP-40) to a final concentration of 1% (v/v),
and centrifuged for 6 min at 14,000 g at 4 jC. SDS at a
final concentration of 0.2% (w/v) is added to the post-
mitochondrial supernatant thus obtained. This is then
extracted twice with phenol/chloroform/isoamyl alcohol
(24:24:1, v/v/v) and centrifuged for 5 min at 14,000 g at
4 jC (the aqueous-upper phase is collected), then once with
chloroform/isoamyl alcohol (24:1, v/v) and centrifuged as
Table 1
RT-PCR primers and conditions used for PCR
Region 5V and 3V
primera
Primer sequences (5V–3Vs) Product
size (bp)
A A1R 124 CGAGAGACCATGCAGAGGTC 1108
A1L 1232 GCTCCAAGAGAGTCATACCA
B B1R 998 GACAAACAGAACTGAAACTG 974
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and 2.5 volumes of ice-cold 100% ethanol are added to the
aqueous phase and left overnight at  20 jC for RNA
precipitation. RNA is collected by centrifugation at
10,000 g, 4 jC for 30 min, the pellet is re-suspended in
20–30 Al of DEPC-treated water (see Footnote 1) containing
50 AM ATC acid and the absorbance is measured as above.B1L 1972 GACAAACAGAACTGAAACTG
C C1R 1777 GTGGAGGTCAACGAGCAAGA 849
C1L 2626 ACTCCTTTAAGTCTTCTTCG
D D1R2490 GACAACAGCATCCACACGAA 793
D1L 3283 AATTGGACTCCTGCCTTCAG
E E1R 3055 AGATTCTCCAAAGATATAGC 768
E1L 3824 GAAATGTTGTCTAATATGGC
F F1R 3722 ACGTGAAGAAAGATGACATC 950
F1L 4672 CGAGCTCCAATTCCATGAGC
1 F5for  53 TCGGCTTTTAACCTGGGCAGTG 476
B1rev 425 TGTACTGCTTTGGTGACTTCCCC
2 F12for 399 TTTAGGGGAAGTCACCAAAGCAG 705
B15rev1104 GGGAAGCACAGATAAAAACACCAC
3a F23for 1051 AGCTCAGCCTTCTTCTTCTCAGG 1082
B21rev 2133 GTGTAAGGTCTCAGTTAGGATTG
3b F2for 1616 CTGGATTATGCCTGGCACCATTAA 517
B21rev 2133 GTGTAAGGTCTCAGTTAGGATTG
3c F3for 1714 GAGGACATCTCCAAGTTTGCAGAG 800
B10rev 2514 CACTTTTCGTGTGGTTGCTGTTG
4a F7for 2478 CATTCACCGAAAGACAACAGCATC 1043
B19rev 3521 CCAACTCTTCCTTCTCCTTCTCCTG
4b F8for 2782 CTTGGAAACACTCCTCTTCAA 739
B19rev 3521 CCAACTCTTCCTTCTCCTTCTCCTG
5a F40for 3591 GGATAGCTTGATGCGATCTGTGAG 1028
B40rev 4619 CAATTCCATGAGCAAATGTCCC
5b F10for 4655 TCGTGGAACAGTTACCTCTGCC 738
B11rev 5393 AGGTCTGTGAGCTTGTCACTTTCTG
Annealing temperature for all primer sets is 60 jC; extension time 3 min for
primer pairs A–F and 2 min for primer pairs 1–5b.
a Number represents the 5V-end base on cDNA sequence based on
EMBL/GenBank accession nos. M55106–M55131 and Riordan et al. [9].3. RNA analysis by RT-PCR preparation
3.1. Analysis of the CFTR gene transcript by RT-PCR
Good quality RNA can be prepared from any of the
above methods, if the RNA is stored under ethanol at  20
jC, prior to using centrifuge (10,000 g) at 4 jC for 15 min
and after removing the supernatant, the pellet is allowed to
air-dry on ice. RNA is then re-suspended in DEPC-treated
TE (10 mM Tris; 0.1 mM EDTA) or water to a concentra-
tion of 0.2–1 Ag/Al. One microgram RNA is added to 50 ng
reverse PCR primer in DEPC-treated water or TE in a total
volume of 9.5 Al, covered with mineral oil and incubated at
65 jC for 10 min. ‘‘No RNA’’ and ‘‘no reverse transcriptase
(RT)’’ controls should always be included. The tubes are
snap-cooled on ice and 10.5 Al of RT reaction mix is added
to give final concentrations of 1RT buffer (5RT: 250
mM Tris–HCl; pH 8.5; 375 mM KCl; 15 mM MgCl2), 1 U/
Al RNAse inhibitor and 1.25 mM dNTPs. MMLV reverse
transcriptase (200 U) or Superscript (20 U) is added to all
tubes except the ‘‘no-RT’’ control tube. First-strand cDNA
can also be synthesized using hexanucleotide primers and
MuLV reverse transciptase (GeneAmp Kit, Roche, Basel,
Switzerland) in a final reaction volume of 20 Al containing 5
mM MgCl2; 1 PCR buffer; 1 mM of each of the dNTPs; 1
U/Al MuLV reverse transcriptase; 2.5 AM random hexamers
and 0.5–1 Ag mRNA. The reactions are incubated at 42 jC
for 1 h and then snap-chilled on ice. PCR pre-mix is then
added to give final concentrations of 1 PCR buffer
(10 PCR buffer: 0.67 M Tris–HCl (pH 8.8); 67 mM
EDTA; 0.17 M (NH4)2SO4); 100 ng/Al each of forward
and reverse primers; 170 Ag/ml bovine serum albumin
(BSA); 10 mM h-mercaptoethanol; 3 U Taq polymerase,
e.g. Amplitaq from ROCHE). The conditions for the PCR
included initial denaturation for 5 min, followed by 30
cycles of 1 min at 94 jC, 1 min at 60 jC, 2–3 min (see
Table 1) at 72 jC and 5 min at 72 jC for the final extension.
The sequences of the CFTR cDNA primer pairs A–F [7]
used for the PCR are included in Table 1 and elsewhere [1].
Alternatively, PCR is performed using HotStar Taq poly-
merase mastermix (Qiagen) in a final volume of 50 Al which
includes 5–10 Al of first strand cDNA, 25 Al HotStar
mastermix and 0.1 AM of each primer. The sequences of
the CFTR cDNA primer pairs 1–5b (most of which are
internal to primer sets A–F) are included in Table 1. The
PCR thermal cycling conditions are as follows: initial
denaturation at 95 jC for 15 min; 30–36 cycles of 95 jCfor 30 s, annealing at 60 jC for 1 min and extension at 72 jC
for 2 min followed by a final extension at 72 jC for 8 min.
The success of the PCR is tested by running 5 Al of the
product on a 1.5% agarose gel and staining with ethidium
bromide. For fluorescent detection applications, one of the
primer pairs is labelled with fluorescent dyes, e.g. Fam,
Texas Red, Cy3, Cy5 [3,8].
3.2. OneStep RT-PCR method to determine low levels of
CFTR mRNA in real time: application to nasal epithelium
cells
Cells from respiratory epithelium are obtained by nasal
brushing of both nostrils [4]. Using the OneStep RT-PCR kit
(Qiagen, cat. no. 210210) 2 Al of total RNA (20–200 ng)
are reverse-transcribed and directly amplified in the same
glass capillary of a LightCyclerk system (Roche). Online
fluorescence monitoring is performed by adding SYBR
Green I (Sigma, St. Louis, USA). The final reaction volume
is 20 Al (1RT-PCR buffer: 12.5 mM MgCl2, 400 AM of
each dNTP, 0.6 AM of each primer, 1:2 105 dilution of
freshly prepared SYBR Green I. 0.375 U/Al RNase inhib-
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LightCyclerk RT conditions are as follows: 30 min at 50
jC, 15 min at 95 jC followed by the quantitative real-time
PCR for 45 cycles of 95 jC for 0 s, 58 jC for 30 s and 72
jC for 15 s. Fluorescence is measured at the end of the
elongation phase with the final melting curve analysis done
from 58 to 95 jC with a slope of 0.1 jC/s. Primers used for
the detection of CFTR transcripts with exon 9 are RTCF9/10
and for the CFTRex9del transcripts (exon 9 omitted) RTCF
8/10 with RTCF10 reverse primer for both (RTCF9/
10:5VCACTGGAGCAGGCAAGACTTC3; TCF8/
10:5VAGCCTTCTGGGAGGAGACTTC3V; RTCF10:
5VCATGCTTTGATGACGCTTCTG-3V).4. Ribonuclease protection assay for CFTR RNA
analysis
4.1. Introduction
The ribonuclease protection assay (RPA) is a highly
sensitive and specific method for the detection, quantifica-
tion and characterization of mRNA species. The assay
exploits the DNA-dependent RNA polymerases from the
bacteriophages SP6, T7 and T3. A cDNA fragment of
interest (e.g. a CFTR sequence) [10] is first subcloned into
a plasmid that contains bacteriophage promoters (e.g. TA
vector (Invitrogen, Paisley, UK) or the Bluescript KS
(Stratagene, California. USA), and the construct is then
used as a template for the synthesis of radiolabelled anti-
sense RNA probes. The cloned fragments should range in
size from 100 to 300 nucleotides. The orientation of the
insert must direct the synthesis of complementary (anti-
sense) RNA. The construct should also be digested with a
restriction enzyme producing 5V overhanging ends, to create
a linear template that will be transcribed into a 100- to 300-
base run-off transcript. As internal control probes, glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) or h-actin
mRNA fragments can be used. The probe is hybridized in
excess to target RNA, in solution after which free probe and
other single-stranded RNA are digested with RNases. The
remaining ‘‘RNase-protected’’ probes are purified, resolved
on denaturing polyacrylamide gel, and quantified by auto-
radiography or phosphorimaging. The quantity of each
mRNA species in the original RNA sample can then be
determined based on the intensity of the appropriately sized,
protected probe fragment. The assay is highly specific and
quantitative due to the RNase sensitivity of mismatched
base pairs (or non-paired bases) and to solution-phase
hybridization driven towards completion by usage of excess
probe.
4.2. Assays
First a single-stranded cRNA probe labelled with a-32P-
UTP (or a-32P-GTP) is generated and purified from 10 Ag oflinearized plasmid and re-suspended in an equal volume of
2 proteinase K buffer (200 mM Tris–HCl; 25 mM
EDTA; 300 mM NaCl; 2% (w/v) SDS; 200 mg/ml protein-
ase K; pH 7.5). The mixture is incubated for 30 min at 37
jC, extracted with phenol/chloroform followed by ethanol
precipitation at  20 jC and re-suspended at 1 mg/ml in
water. For in vitro transcription, the MAXIscript in vitro
Transcription Kit (Ambion, Austin, TX, cat. no. 1308) is
used according to the manufacturer’s instructions. The probe
is purified with the QIAquick nucleotide removal kit (Qia-
gen, cat. no. 28304) or alternatively with a protocol avail-
able online[11]. The probe is checked in a scintillation
counter a-32P channel (good yield for 1 Al in the range of
5 105 to 6 106 counts per minute (cpm); for low
abundance CFTR mRNA expect 0.5 105 cpm of the
labelled antisense probe to 20 Ag of total RNA) and stored
at  20 jC until needed. Alternatively, the probe can be
purified by electrophoresis in a 5% (w/v)/8 M urea poly-
acrylamide gel [12]. The relevant band is excised and eluted
overnight at room temperature in 350 Al elution buffer. The
specific radioactivity is determined and the solution is stored
at  20 jC without removal of the gel fragment. For the
(CFTR) RNA preparation procedures that generate total
RNA of high quality and purity (RNeasyk Qiagen kit, or
Trizolk from Invitrogen followed by phenol/chloform
extraction) can be used, always performing DNase I diges-
tion. For the hybridization experiment, the RPAIIk or the
RPAIIIk kit (Ambion, cat. no. 1410 or 1415, respectively)
can be used, according to the manufacturer’s instructions.
Alternatively, the desired amount of target RNA (1–20 Ag)
is solubilized in 8 Al of hybridization buffer (40 mM PIPES;
0.4 M NaCl; 1 mM EDTA; pH 8.0; 80% (v/v) formamide;
pH 6.4), in a microfuge tube, a negative control containing
yeast tRNA is also included. The probe is diluted with
hybridization buffer to the appropriate concentration (the
probe must be in excess for accurate quantification) and 2
Al of the diluted probe is added to each RNA sample and
mixed by pipetting. The hybridization mix is heated to 95
jC for 3 min and incubated at 44 jC/55 jC overnight. The
tubes are placed in a heat block at 37 jC for 15 min prior to
the RNase treatment. For the RNase assay, the samples are
removed from the heat block and 200 Al of the RNase buffer
(300 mM NaCl; 10 mM Tris; 5 mM EDTA; pH 8.0; 40 Ag/
ml RNaseA; 2 U/ml RNaseT1; pH 7.5) is added. The
samples are spun in the microfuge for 10 s and incubated
at 37 jC for 20 min, followed by the addition of 1.7
Al proteinase K (20 mg/ml) and 13.6 Al 10% (w/v) SDS,
vortexed quickly, re-spun and incubated at 37 jC for a
further 20 min. The solution is cleaned up by extracting with
500 Al phenol/chloroform/isoamyl alcohol (25:24:1 v/v/v),
vortexed and spun for 10 min. The aqueous phase is
transferred to a new tube and 4.5 Al (30 Ag) of tRNA (or
20 Ag of glycogen) and 500 Al of 100% ethanol is added and
immediately spun for 15 min at room temperature. The
ethanol is aspirated and the RNA pellet is allowed to air dry
and re-suspended in 5 Al of loading buffer (80% (v/v)
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xylene cyanol; 1 mM EDTA; pH 8.0). The samples are
denatured at 100 jC for 5 min and chilled on ice prior to
loading 5–10 Al on an 8 M urea denaturing 6% (w/v)
polyacrylamide gel and electrophoresis proceeded at 20–
25 V/cm. The gel is dried at 80 jC under vacuum and
exposed to an X-ray film overnight. The results are visual-
ized by autoradiography.Acknowledgements
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